These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9500578)

  • 1. Mechanisms of elevation of serum and urinary concentrations of soluble thrombomodulin in diabetic patients: possible application as a marker for vascular endothelial injury.
    Aso Y; Inukai T; Takemura Y
    Metabolism; 1998 Mar; 47(3):362-5. PubMed ID: 9500578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High plasma homocysteine concentrations are associated with plasma concentrations of thrombomodulin in patients with type 2 diabetes and link diabetic nephropathy to macroangiopathy.
    Okumura K; Aso Y
    Metabolism; 2003 Nov; 52(11):1517-22. PubMed ID: 14624417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating thrombomodulin and hematological alterations in type 2 diabetic patients with retinopathy.
    Fujiwara Y; Tagami S; Kawakami Y
    J Atheroscler Thromb; 1998; 5(1):21-8. PubMed ID: 10077454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated serum and urinary thrombomodulin levels in patients with non-insulin-dependent diabetes mellitus.
    Shimano H; Takahashi K; Kawakami M; Gotoda T; Harada K; Shimada M; Yazaki Y; Yamada N
    Clin Chim Acta; 1994 Mar; 225(2):89-96. PubMed ID: 8088010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial markers, von Willebrand factor and thrombomodulin index, are specifically elevated in type 2 diabetic patients with nephropathy: comparison of primary renal disease.
    Hirano T; Ookubo K; Kashiwazaki K; Tajima H; Yoshino G; Adachi M
    Clin Chim Acta; 2000 Sep; 299(1-2):65-75. PubMed ID: 10900293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of ramipril on the course of plasma thrombomodulin in patients with diabetes mellitus.
    Borcea V; Morcos M; Isermann B; Henkels M; Ziegler S; Zumbach M; Amiral J; Längst KD; Seiz W; Ziegler R; Wahl P; Nawroth PP
    Vasa; 1999 Aug; 28(3):172-80. PubMed ID: 10483322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of measurements of urinary and serum thrombomodulins in patients with non-insulin-dependent diabetes mellitus.
    Inukai T; Fujiwara Y; Tayama K; Aso Y; Takemura Y
    Diabetes Res Clin Pract; 1996 Jul; 33(2):99-104. PubMed ID: 8879964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of soluble thrombomodulin in sera from various clinical stages of diabetic nephropathy.
    Rinno H; Kuramoto T; Iijima T; Yagame M; Tomino Y
    J Clin Lab Anal; 1996; 10(3):119-24. PubMed ID: 8731497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between soluble thrombomodulin in plasma and coagulation or fibrinolysis in type 2 diabetes.
    Aso Y; Fujiwara Y; Tayama K; Takebayashi K; Inukai T; Takemura Y
    Clin Chim Acta; 2000 Nov; 301(1-2):135-45. PubMed ID: 11020468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum and urinary levels of insulin-like growth factor I in patients with chronic renal disease and diabetes mellitus: its clinical implication.
    Fujihara M; Uemasu J; Kawasaki H
    Clin Nephrol; 1996 Jun; 45(6):372-8. PubMed ID: 8793228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevation of soluble thrombomodulin antigen levels in the serum and urine of streptozotocin-induced diabetes model rats.
    Nakano M; Furutani M; Shinno H; Ikeda T; Oida K; Ishii H
    Thromb Res; 2000 Jul; 99(1):83-91. PubMed ID: 10904105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus.
    Kim NH; Kim KB; Kim DL; Kim SG; Choi KM; Baik SH; Choi DS; Kang YS; Han SY; Han KH; Ji YH; Cha DR
    Diabet Med; 2004 Jun; 21(6):545-51. PubMed ID: 15154937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of urinary excretion of albumin, alpha 1-microglobulin and retinol-binding protein in diabetic patients.
    Galanti LM; Jamart J; Dell'omo J; Donckier J
    Diabetes Metab; 1996 Oct; 22(5):324-30. PubMed ID: 8896994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for amelioration of endothelial cell dysfunction by erythropoietin therapy in predialysis patients.
    Kuriyama S; Hopp L; Yoshida H; Hikita M; Tomonari H; Hashimoto T; Sakai O
    Am J Hypertens; 1996 May; 9(5):426-31. PubMed ID: 8735172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteinuria in newly diagnosed type II diabetic patients.
    Uusitupa M; Siitonen O; Penttilä I; Aro A; Pyörälä K
    Diabetes Care; 1987; 10(2):191-4. PubMed ID: 3556105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta2-microglobulin and cystatin C in type 2 diabetes: assessment of diabetic nephropathy.
    Aksun SA; Ozmen D; Ozmen B; Parildar Z; Mutaf I; Turgan N; Habif S; Kumanlioğluc K; Bayindir O
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):195-200. PubMed ID: 15127324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial markers in diabetes mellitus.
    Galajda P; Martinka E; Mokán M; Kubisz P
    Thromb Res; 1997 Jan; 85(1):63-5. PubMed ID: 8983126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma thrombomodulin: a marker for microvascular complications in diabetes mellitus.
    Gabat S; Keller C; Kempe HP; Amiral J; Ziegler R; Ritz E; Bergis KH; Wahl P; Nawroth P
    Vasa; 1996; 25(3):233-41. PubMed ID: 8795304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma thrombomodulin in primary glomerular disease and lupus glomerulonephritis.
    Tomura S; Deguchi F; Ando R; Ida T; Chida Y; Uchiyama T; Matsuda O; Marumo F
    Nephron; 1994; 67(2):185-9. PubMed ID: 8072607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between serum 1,5-anhydroglucitol and urinary excretion of N-acetylglucosaminidase and albumin determined at onset of NIDDM with 3-year follow-up.
    Yamanouchi T; Kawasaki T; Yoshimura T; Inoue T; Koshibu E; Ogata N; Funato H; Akaoka I; Miyashita H
    Diabetes Care; 1998 Apr; 21(4):619-24. PubMed ID: 9571353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.